Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney

Clarice Kazue Fujihara1, Gláucia Rutigliano Antunes, Ana Lúcia Mattar

  • 1Renal Division, Department of Clinical Medicine, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.

Kidney International
|November 25, 2003
PubMed
Abstract

Insights

Chronic cyclooxygenase-2 (COX-2) inhibition reduced kidney damage in a rat model of progressive nephropathy. Celecoxib treatment attenuated hypertension and inflammation, highlighting COX-2

Area of Science:

  • Nephrology
  • Pharmacology
  • Renal Pathophysiology

Background:

  • Progressive nephropathies involve hemodynamic and inflammatory pathways.
  • Cyclooxygenase-2 (COX-2) expression increases in the 5/6 nephrectomy model.
  • NSAIDs and COX-2 inhibitors show renoprotective effects.

Purpose of the Study:

  • Investigate renal cyclooxygenase-2 (COX-2) distribution in 5/6 nephrectomy rats.
  • Elucidate hemodynamic and cellular mechanisms of COX-2 inhibition in preventing renal injury.

Main Methods:

  • Adult male Munich-Wistar rats underwent 5/6 nephrectomy or sham operation.
  • Groups received either vehicle or celecoxib (10 mg/kg/day) orally.
  • Renal hemodynamics assessed at 4 weeks; morphology and immunohistochemistry at 8 weeks.

Main Results:

  • Celecoxib attenuated systemic and glomerular hypertension in nephrectomized rats.
  • Glomerulosclerosis and interstitial expansion were reduced by celecoxib.
  • COX-2 expression was observed in macula densa, glomeruli, arterioles, and interstitium, with celecoxib reducing ectopic expression.

Conclusions:

  • Chronic COX-2 inhibition mitigated progressive nephropathy in rats.
  • Reduced glomerular hypertension and renal inflammation were key effects.
  • COX-2 plays a complex role in progressive renal injury after 5/6 nephrectomy.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...